XML 38 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:
3 Months Ended
Jun. 30, 2013
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:  
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

2.             EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY:

 

Earnings Per Share

 

A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
June 30

 

 

 

2013

 

2012

 

Basic earnings per share:

 

 

 

 

 

Net earnings

 

$

13,095

 

$

13,199

 

Net loss attributable to noncontrolling interest

 

(85

)

(134

)

Net earnings attributable to Acxiom

 

$

13,180

 

$

13,333

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

73,679

 

76,473

 

Basic earnings per share:

 

 

 

 

 

Net earnings

 

$

0.18

 

$

0.17

 

Net loss attributable to noncontrolling interest

 

 

 

Net earnings attributable to Acxiom

 

$

0.18

 

$

0.17

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

Basic weighted-average shares outstanding

 

73,679

 

76,473

 

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method

 

1,812

 

1,584

 

Diluted weighted-average shares outstanding

 

75,491

 

78,057

 

Diluted earnings per share:

 

 

 

 

 

Net earnings

 

$

0.17

 

$

0.17

 

Net loss attributable to noncontrolling interest

 

 

 

Net earnings attributable to Acxiom

 

$

0.17

 

$

0.17

 

 

As of June 30, 2013, the Company had options and warrants outstanding providing for the purchase of approximately 9.4 million shares of common stock together with restricted stock units relating to 2.2 million shares of stock. Options, warrants and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
June 30

 

 

 

2013

 

2012

 

Number of shares outstanding under options, warrants and restricted stock units

 

4,018

 

8,117

 

Range of exercise prices for options and warrants

 

$21.06-$62.06

 

$13.74-$62.06

 

 

Stockholders’ Equity

 

On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded on December 5, 2011, on May 24, 2012, and again on February 5, 2013.  Under the modified common stock repurchase program, the Company may purchase up to $200.0 million worth of its common stock through the period ending February 5, 2014.  During the quarter ended June 30, 2013, the Company repurchased 0.7 million shares of its common stock for $16.1 million.  Through June 30, 2013, the Company had repurchased 11.1 million shares of its stock for $156.1 million, leaving remaining capacity of $43.9 million under the stock repurchase program.

 

Accumulated Other Comprehensive Income

 

The accumulated balances for each component of other comprehensive income are as follows (dollars in thousands):

 

 

 

June 30,
2013

 

March 31,
2013

 

Foreign currency translation

 

$

9,428

 

$

12,175

 

Unrealized loss on interest rate swap

 

(554

)

(752

)

 

 

$

8,874

 

$

11,423